Identification of tuberculosis-associated proteins in whole blood supernatant

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Tanaka, Takahiro ^a,b   Sakurada, Shinsaku ^b   Kano, Keiko ^b   Takahashi, Eri ^b,c   Yasuda, Kazuki ^b   Hirano, Hisashi ^c   Kaburagi, Yasushi ^b   Kobayashi, Nobuyuki ^b   Le Hang, Nguyen T ^d   Lien, Luu T ^e   Matsushita, Ikumi ^b   Hijikata, Minako ^b   Uchida, Takafumi ^a   Keicho, Naoto ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d BACH MAI HOSPITAL   (Viet Nam)

^e Hanoi Tuberculosis and Lung Disease Hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 GLYCOPROTEIN; ALPHA2 GLYCOPROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN C2; BACTERIAL ANTIGEN; CLUSTERIN; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; FETUIN A; KININOGEN; RETINOL BINDING PROTEIN 4; VITAMIN D BINDING PROTEIN; ALPHA2HS GLYCOPROTEIN; MYCOBACTERIUM TUBERCULOSIS ANTIGENS; PLASMA PROTEIN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOSTIMULATION; INCUBATION TIME; LUNG TUBERCULOSIS; MALE; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SUPERNATANT; TWO DIMENSIONAL GEL ELECTROPHORESIS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ADULT; AGED; ANTIGENS, BACTERIAL; BLOOD PROTEINS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; RETINOL-BINDING PROTEINS, PLASMA; TUBERCULOSIS, PULMONARY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 79953069100     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-71     Document Type: Article

References (19)

1. WHO Global Tuberculosis Control: Epidemiology, Strategy, Financing. Geneva. 2009, 7-13. WHO Press, WHO.
2. Jacobsen M, Repsilber D, Guschmidt A, et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 2007, 85:613-621. 10.1007/s00109-007-0157-6, 17318616.
3. Mistry R, Cliff JM, Clayton CL, et al. Gene expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 2007, 195:357-365. 10.1086/510397, 17205474.
4. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021. 10.1016/S0140-6736(06)69342-2, 16980117.
5. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009, 9:21. 10.1186/1471-2466-9-21, 2696407, 19445695.
6. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375:1920-1937. 10.1016/S0140-6736(10)60359-5, 20488517.
7. Toda T, Sugimoto M, Omori S, Matsuzaki T, Furuichi Y, Kimura N. Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization. Electrophoresis 2000, 21:1814-1822. 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.0.CO;2-#, 10870967.
8. Saeki K, Yasugi E, Okuma E, Breit SN, Nakamura M, Toda T, Kaburagi Y, Yuo A. Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab 2005, 289:E419-428. 10.1152/ajpendo.00512.2004, 15827065.
9. Seth M, Lamont EA, Janagama HK, Widdel A, Vulchanova L, Stabel JR, Waters WR, Palmer MV, Sreevatsan S. Biomarker discovery in subclinical mycobacterial infections of cattle. PLoS One 2009, 4:e5478. 10.1371/journal.pone.0005478, 2674942, 19424492.
10. Crowle AJ, Ross EJ. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 1989, 57:840-844. 313186, 2492972.
11. Jersmann HP, Dransfield I, Hart SP. Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci 2003, 105:273-278. 10.1042/CS20030126, 12725640.
12. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA 1998, 95:14429-14434. 10.1073/pnas.95.24.14429, 9826717.
13. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362. 10.1038/nature03711, 16034410.
14. Dziegielewska KM, Brown WM, Deal A, Foster KA, Fry EJ, Saunders NR. The expression of fetuin in the development and maturation of the hemopoietic and immune systems. Histochem Cell Biol 1996, 106:319-330. 10.1007/BF02473242, 8897073.
15. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA 1998, 95:14429-14434. 10.1073/pnas.95.24.14429, 24390, 9826717.
16. Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A, Scher LA, Friedman SG, Tracey KJ. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 2001, 15:181-185. 10.1097/00024382-200115030-00004, 11236900.
17. Jersmann HP, Dransfield I, Hart SP. Fetuin/α2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond) 2003, 105:273-278. 10.1042/CS20030126, 12725640.
18. Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD. Mineral chaperones:a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008, 86:379-389. 10.1007/s00109-007-0294-y, 18080808.
19. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shilipak MG. Fetuin-A and incident diabetis mellitus in older persons. JAMA 2008, 300:182-188. 10.1001/jama.300.2.182, 2779582, 18612115.